SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008761
Filing Date
2017-11-13
Accepted
2017-11-09 18:17:05
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mer-20170930x10q.htm 10-Q 1545554
2 EX-10.1 mer-20170930ex101b7addc.htm EX-10.1 38615
3 EX-31.1 mer-20170930ex311d00466.htm EX-31.1 10981
4 EX-31.2 mer-20170930ex312295ab3.htm EX-31.2 13077
5 EX-32.1 mer-20170930ex32169c7cd.htm EX-32.1 15631
  Complete submission text file 0001558370-17-008761.txt   6079692

Data Files

Seq Description Document Type Size
6 EX-101.INS mer-20170930.xml EX-101.INS 1115072
7 EX-101.SCH mer-20170930.xsd EX-101.SCH 62516
8 EX-101.CAL mer-20170930_cal.xml EX-101.CAL 38319
9 EX-101.DEF mer-20170930_def.xml EX-101.DEF 235320
10 EX-101.LAB mer-20170930_lab.xml EX-101.LAB 451260
11 EX-101.PRE mer-20170930_pre.xml EX-101.PRE 360725
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 171192264
SIC: 2834 Pharmaceutical Preparations